Rosa roxburghii

Rosa roxburghii Tratt (Chestnut Rose / Cili): A Comprehensive Reference

1. Identity and Botanical Description

Nomenclature and Taxonomy

Rosa roxburghii Tratt, commonly known as the chestnut rose or Burr rose, is classified within the plant kingdom as an angiosperm (eudicot), in the order Rosales, family Rosaceae, genus Rosa, and species roxburghii. The full binomial designation is Rosa roxburghii Trattinnick, where "Tratt" refers to the botanist Leopold Trattinnick who formally described the species. In Chinese, the plant is widely known as Cili (刺梨) or Thorn Pear, reflecting the spiny surface of its distinctive fruits. It is an emerging functional fruit native to southwestern China, characterized by extraordinarily high vitamin C content, robust superoxide dismutase (SOD) activity, and a rich diversity of bioactive compounds.

Morphology and Natural Distribution

Morphologically, R. roxburghii is a deciduous shrub or tree of varying sizes with a distinct branching pattern. R. roxburghii Tratt (RRT) is a perennial deciduous plant in the Rosa genus of the Rosaceae family, mainly growing in the karst areas of southwestern China at altitudes of 500–2500 m. The fruit surface is covered with numerous stiff, prickle-like projections, giving it the characteristic "burr" or "chestnut" appearance from which its common names derive. Its leaves are alternately arranged and pinnately compound.

Common Forms and Preparations

The whole of the R. roxburghii plant is edible (including fruits, leaves, and roots) and it has traditionally been used in Chinese folk medicine. In recent years, some food products have been developed from R. roxburghii fruits, such as tea, vinegar, jam, yogurt, preserved fruit, and cake. R. roxburghii fruit can be consumed fresh or in processed forms, such as juice, dried and canned products, yoghurt, and wine; however, the fresh fruit has low acceptance for direct consumption due to its astringent taste. As a dietary supplement, R. roxburghii is marketed in several forms including juice concentrates, freeze-dried powders, standardized fruit extracts (often standardized to vitamin C or SOD content), fermented juice, vinegar, and encapsulated polyphenol extracts. Leaf-based tea is also a documented preparation form.

2. Traditional and Historical Use

Chinese Folk Medicine and Diet

RRT holds a prominent place in traditional Chinese medicine and culture, and its various parts — fruit, roots, leaves, flowers, and seeds — are used for medicinal and culinary purposes. It is recorded in the "Dictionary of Traditional Chinese Medicine" that all the flowers, fruits, leaves, roots, and seeds of R. roxburghii can be used as medicine, with effects of invigorating the stomach, aiding digestion, and nourishing, and the root bark has the effect of stopping diarrhea. Meanwhile, R. roxburghii has also been used in folk medicine to treat stomach distension, hemorrhoids, dysentery, and other diseases.

Traditionally, it is used to eliminate dietary stagnation and relieve diarrhea, nourish Yin and invigorate the spleen, dispel wind and dampness, and enhance immunity, and it has promoted healthy development of the body. Furthermore, it has served as a remedy for ailments such as scurvy, night blindness, cancer, hyperlipidemia, hyperglycemia, and hypertension.

Traditional Uses in Southwestern China

In southwestern China, RRT is an ingredient of a traditional herbal soup used to treat malignant tumors. Rosa roxburghii Tratt is reputed to have benefits in improving immune responses, enhancing digestive ability, and demonstrating anti-aging effects.

Historical Fermented Preparations

The most widespread traditional use of R. roxburghii is for brewing R. roxburghii wine. The origin of this wine in Guizhou was recorded very early in the Daoguang Years of the Qing Dynasty. The "Annals of Guiyang Prefecture" of the same year described how "people in Guizhou Province pick R. roxburghii fruits, steam them, dry them in the sun, wrap them in cloth, then brew them in a jar full of wine to get R. roxburghii wine, which tastes great."

Traditional Leaf Tea

Rosa roxburghii Tratt tea is a traditional Chinese beverage. The leaves were brewed as an everyday health-promoting drink, particularly in Guizhou and adjacent provinces of southwestern China.

3. Key Constituents and Active Compounds

Primary Phytochemical Profile

The chemical profile of R. roxburghii is characterized by the presence of essential nutrients such as vitamin C (ascorbic acid), flavonoids, triterpenes, organic acids, tannins, phenolic compounds, polysaccharides, carotenoids, triterpenoids, volatile compounds, amino acids, and essential oils. It contains many nutritious and active ingredients, including proteins, vitamin C, inorganic salts, essential amino acids, polysaccharides, phenols, triterpenes, organic acids, and superoxide dismutase (SOD).

Vitamin C (Ascorbic Acid)

The content of vitamin C (Vc) in R. roxburghii is 11 times higher than that of kiwifruit. This extraordinarily high ascorbic acid content is one of the plant's most distinguishing phytochemical features and has been recognized since the 1940s when early threpsological and biochemical studies confirmed high vitamin C levels in the fruit. The SOD and ascorbic acid in fruit of R. roxburghii can balance oxidative stress in humans.

Superoxide Dismutase (SOD)

The activity of superoxide dismutase (SOD) in R. roxburghii is about 10,000 U/mL, which is 20 to 50 times higher than that of grapes. The fruit of R. roxburghii is well known for containing the largest amount of superoxide dismutase (SOD) compared with other common fruits. SOD is an enzyme that catalyzes the dismutation of superoxide radicals into hydrogen peroxide and molecular oxygen, functioning as a critical antioxidant defense molecule.

Flavonoids and Polyphenols

The content of total flavonoids is 12,895 mg/100 g — 360 times that of citrus — and polyphenol content reaches up to 1,590 mg/100 g. A total of 37 phenolic compounds have been characterized and quantified by UPLC-Q-Exactive Orbitrap/MS, with ellagic acid, quercitrin, isoquercitrin, and quinic acid in the free fraction, while gallic acid, ellagic acid, and hyperoside were the main compounds in the bound fraction. Key identified polyphenols include chlorogenic acid, quercitrin, and ellagic acid.

Proanthocyanidins and Tannins

A proanthocyanidin-rich Cili fruit extract (PACs-CFE) has been developed containing 84.2% total proanthocyanidins, comprising catechins, epicatechins, and diverse B-type dimers, trimers, tetramers, and gallate esters. Ellagitannins are also documented constituents; ellagitannin (praecoxin A) has been identified among the compounds, and ellagitannins are known to possess significant antioxidant, anticancer, and antitumor activities.

Triterpenoids and Sterols

Pentacyclic triterpenoids emerge as the predominant terpenoid class, comprising more than 33 identified structures characterized primarily as polyhydroxylated ursane- and oleanane-type scaffolds alongside their corresponding glycosides. Additionally, approximately 15 sesquiterpenoids, largely monocyclic variants and their glycosidic derivatives, have been documented. Recent phytochemical investigation has further yielded novel alkaloids: fresh fruits of R. roxburghii have yielded two new dihydroavicine alkaloids, roxburghcids D and E, and a new triterpenoid glycoside, roxburghcid C, together with five known compounds.

Polysaccharides

Among the bioactive components, polysaccharides stand out as pivotal constituents comprising mannose, ribose, rhamnose, glucosamine hydrochloride, glucuronic acid, galacturonic acid, glucose, galactose, and arabinose. Polysaccharides in the fruit of R. roxburghii inhibit digestive enzymes such as α-amylase and α-glucosidase, slowing the absorption rate of dietary carbohydrates in the small intestine.

Additional Nutrients

The fruit contains more than 20 kinds of amino acids, including 8 kinds of essential amino acids, 5 kinds of fatty acids, and 18 kinds of inorganic salts as well as more than 10 kinds of trace elements beneficial to the human body.

Maturation-Dependent Variation

During the ripening process, the levels of total acid, vitamin C, and soluble sugar significantly increase, while the levels of total flavonoids, superoxide dismutase (SOD), and soluble tannin significantly decrease. Additionally, the content of total phenol exhibits a trend of first decreasing significantly and then increasing significantly. This indicates that the precise phytochemical profile of the fruit is strongly influenced by harvest time and ripening stage.

4. Mechanisms of Action

Antioxidant Mechanisms

Vitamin C and SOD extracts from R. roxburghii show strong inhibitory activity against various free radicals and tyrosinase. The co-presence of ascorbic acid and SOD creates a synergistic antioxidant system: when formulated together, antioxidant abilities are significantly enhanced, with the optimal ratio of vitamin C to SOD extract being 5:32. The polyphenolic constituents, particularly ellagic acid and quercitrin, contribute to radical scavenging via hydrogen atom and electron transfer mechanisms. Compounds isolated from the fruit exhibit significant ABTS radical scavenging activities, with IC50 values in the micromolar range.

Anti-Inflammatory Mechanisms

Network pharmacological analysis and molecular docking results suggest that isolated compounds from the roots may treat inflammation by binding TNF-α and IL-6 targets, and one compound showed a strong inhibitory effect on IL-6 release in LPS-induced RAW264.7 macrophages. Rosa roxburghii fermented juice has demonstrated the ability to ameliorate TNF-α, IL-6, IL-1β, and IL-10 levels in vivo, thereby improving oxidative stress markers (MPO, SOD, GSH, MDA) in animal models.

Glucose-Regulatory Mechanisms

Polysaccharides in the fruit inhibit digestive enzymes such as α-amylase and α-glucosidase, slowing the absorption rate of dietary carbohydrates in the small intestine, thus potentially preventing type 2 diabetes. Additionally, oral administration of polyphenol-rich extract (RP) from R. roxburghii fruit markedly decreased food intake, water intake, fasting blood glucose (FBG), and serum insulin levels in db/db diabetic mice, and glucose intolerance, insulin resistance, and oxidative stress were ameliorated.

Lipid-Regulatory Mechanisms

Hydroalcoholic extract of R. roxburghii fruit (HRT) significantly reduced body weight gain and decreased serum and liver lipid levels in hyperlipidemic rats. In addition, HRT treatment improved the activities of antioxidant enzymes, lipoprotein lipase, and hepatic lipase, downregulated the mRNA and protein expressions of sterol regulatory element-binding protein 1c and acetyl CoA carboxylase, and upregulated mRNA and protein expressions of peroxisome proliferator-activated receptor α (PPARα) and LDL receptor.

Hepatoprotective Mechanisms

Rosa roxburghii Tratt juice can reduce hepatic 8-OHdG and MDA levels in mice, thereby alleviating liver injury; the hepatoprotective effects are achieved through modulation of nuclear receptor-mediated pathways, including CAR, PXR, and Nrf2 signaling, which collectively reduce oxidative stress and improve lipid metabolism.

Gut Microbiota Modulation

Polysaccharide intake from R. roxburghii Tratt significantly reduced the abundance of LPS-producing Enterobacteriaceae and Desulfovibrionaceae in the gastrointestinal tract, and a decrease in LPS levels was also detected. Metagenomic analysis revealed that Rosa roxburghii fermented juice (RRFJ) intervention reversed the decrease in intestinal flora Alistipes and Colidextribacter in mice fed a high-fat diet.

Anticancer Mechanisms

Network pharmacology analysis indicates that the effects of RRT may be closely associated with multiple signal pathways, including pathways in cancer, PI3K-Akt, and TNF signaling. A proanthocyanidin-rich Cili fruit extract inhibited hepatic stellate cell (LX-2) activation, suppressed collagen III and α-SMA expression, and induced ferroptosis via mitochondrial injury, reactive oxygen species accumulation, and GPX4/ferritin downregulation.

5. Scientific Evidence by Area of Use

5.1 Antioxidant Activity

Preclinical (in vitro and animal) evidence: No cytotoxicity or genotoxicity was observed at levels of up to 5% (v/v) of the fruit extract in cell models. A significant protection against tert-butyl hydroperoxide (t-BHP)-induced oxidative stress was observed in primary rat hepatocytes. The Ames test revealed no mutagenic activity using Salmonella typhimurium strains TA98, TA100, and TA102. A significant antimutagenic effect of the extract was observed against the metabolic-activated mutagens 2-acetylaminofluorene and aflatoxin B1. In vitro antioxidant assays using seed polyphenol extract demonstrated moderate antioxidant capacity, and in vivo evaluations using Caenorhabditis elegans confirmed its ability to extend lifespan, reduce lipofuscin accumulation, and enhance resistance to oxidative and heat stress.

Evidence strength: The antioxidant evidence is well-established in vitro and in animal models. Clinical evidence specific to antioxidant endpoints in humans is limited, though the very high vitamin C and SOD content provides a mechanistic rationale. Evidence in this domain is predominantly preclinical.

5.2 Blood Lipid Regulation and Cardiovascular Effects

Systematic review / meta-analysis: Although recent studies show the hypolipidemic effect of Rosa roxburghii, reported findings are contradictory. Using meta-analysis, the effect of R. roxburghii on blood lipid levels was explored through an extensive literature search. The results showed that R. roxburghii fruit can significantly reduce total cholesterol, triglyceride, and LDL cholesterol levels and increase HDL cholesterol levels. R. roxburghii fruit can therefore be considered a valuable adjuvant therapy for blood lipid control; however, this needs confirmation through additional research.

Animal studies: Mice in the RRFJ intervention group had significantly reduced body weight as well as lower levels of serum and liver lipid indicators compared to the high-fat diet group. Liver metabolomics showed that RRFJ prevented liver dyslipidemia by modulating the biosynthesis of phenylalanine, tyrosine, tryptophan, and phenylalanine metabolism, and was effective in preventing dyslipidemia through the "gut-liver axis."

Evidence strength: Preclinical evidence is substantial. A meta-analysis supports lipid-lowering effects, but the authors explicitly note that conclusions need confirmation from high-quality human clinical trials. Evidence is promising but not yet definitive at the human level.

5.3 Diabetes / Glycemic Regulation

Preclinical studies: A study investigated the hypoglycemic effects of polyphenol-rich R. roxburghii extract (RP) isolated from fruit and four of its constituents on db/db diabetic mice. The results indicated that oral administration of RP and its constituents markedly decreased food intake, water intake, fasting blood glucose (FBG), and serum insulin levels. Glucose intolerance, insulin resistance, and oxidative stress were ameliorated, and histopathological observation revealed that RP could effectively protect the liver against fat damage and dysfunction. Modern pharmacological studies have shown that Rosa roxburghii Tratt has potential anti-diabetic activity.

Mechanistic: Polysaccharides in the fruit inhibit digestive enzymes such as α-amylase and α-glucosidase, slowing the absorption rate of dietary carbohydrates in the small intestine, thus potentially preventing type 2 diabetes.

Evidence strength: Evidence is predominantly preclinical (animal models and mechanistic/in vitro). No well-powered randomized controlled trials in human populations have been identified for glycemic endpoints. Despite the growing research that has demonstrated the anti-diabetic activity of Rosa roxburghii Tratt, the characterization of its effective compounds and the exact mechanisms of action have not been systemically demonstrated.

5.4 Anticancer / Antitumor Activity

In vitro evidence: Some evidence indicates that herbal medicine soups containing extracts from R. roxburghii in combination with Fagopyrum cymosum have efficacy in treating malignant tumors, though underlying mechanisms are far from well understood. A study was undertaken to evaluate anticancer effects and explore molecular mechanisms in vitro by assessing proliferation and apoptosis in three carcinoma cell lines — human esophageal squamous carcinoma CaEs-17, human gastric carcinoma SGC-7901, and pulmonary carcinoma A549.

Network pharmacology / in silico: The effect of RRT may be closely associated with multiple signal pathways, including pathways in cancer, PI3K-Akt, and TNF signaling.

Evidence strength: All current evidence is in vitro or in silico. There are no human clinical trials demonstrating direct anticancer efficacy. This area remains at early, exploratory stages and should not be interpreted as evidence for clinical efficacy in humans.

5.5 Hepatoprotective Effects

Preclinical evidence: In vivo, proanthocyanidin-rich Cili fruit extract (PACs-CFE) ameliorated liver fibrosis, restored hepatic architecture, and improved serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and bilirubin profiles. Moreover, PACs-CFE modulated the TGF-β1/Smad3 signaling pathway and beneficially reshaped the gut microbiota, enriching anti-inflammatory and hepatoprotective genera while reducing pathogenic taxa. The findings show that PACs-CFE exerts multi-targeted anti-fibrotic effects through hepatic stellate cell inactivation, ferroptosis induction, TGF-β1/Smad3 suppression, and gut-liver axis modulation.

Evidence strength: Evidence is entirely preclinical (cell culture and rodent models). No human trials have been identified for hepatoprotective endpoints.

5.6 Gastrointestinal Effects

Preclinical evidence: Compared to the gastric ulcer group, high-dose Rosa roxburghii root treatment (RTH) exhibited statistically significant improvements in the ulcer index, reduced levels of TNF-α, IL-6, and MDA, and increased levels of NO, MTL, iNOS, and PGE2. Moreover, the root extract reversed oral-gut microbial dysbiosis, increasing the relative abundance of beneficial bacteria such as Lactobacillus, Romboutsia, and Limosilactobacillus.

Evidence strength: Preclinical (animal model). No human clinical data identified specifically for gastrointestinal ulcer or digestive endpoints.

5.7 Skin Health

Human clinical evidence (randomized controlled trial): A study evaluated the skin health effects of a novel oral supplement containing Rosa roxburghii, Punica granatum, and rose extracts (RPR); 70 healthy female participants were randomly assigned to either a control group or an RPR group, with the latter ingesting 20 mL of the RPR supplement daily on an empty stomach over 8 weeks. After 8 weeks, the RPR group exhibited significant enhancements in skin hydration, glossiness, elasticity, and skin tone, with increases of 69.02%, 30.48%, 25.97%, and 7.52%, respectively. Concurrently, decreases in skin firmness and melanin levels were observed at 21.17% and 25.06%, respectively. Image analysis indicated a significant reduction in the areas of hyperpigmented spots, under-eye fine lines, and crow's feet by 41.50%, 37.55%, and 29.36%, respectively. Importantly, no adverse effects were observed.

Evidence strength: One randomized single-blind controlled clinical trial (n=70) exists. Limitations include small sample size, single-blind design (not double-blinded), short duration (8 weeks), use of a combined three-ingredient supplement (making it impossible to attribute effects solely to R. roxburghii), and industry affiliation of investigators. Evidence is preliminary.

5.8 Neuroprotective Effects

Preclinical evidence: The fruit derived from Rosa roxburghii Tratt demonstrates a rich profile of biologically active compounds, with flavonoids, triterpenoids, and organic acids representing the predominant classes. Experimental evidence indicates that these compounds elicit robust antioxidative, anti-inflammatory, and neuroprotective effects, making them promising candidates for neurodegenerative disease modulation. Research has been conducted evaluating effects in Parkinson's disease animal models, investigating preventive, interventional, and therapeutic stages via the PI3K/AKT signaling pathway.

Evidence strength: Neuroprotection evidence is entirely preclinical. No human clinical trials have been identified for neurodegenerative indications.

5.9 Immunomodulatory Activity

Pharmacological activities reviewed in the literature include immunomodulatory activity, as well as antioxidant, anti-tumor, glucose and lipid metabolism regulation, anti-radiation, detoxification, and viscera protection activities. Rosa roxburghii Tratt is reputed to have benefits in improving immune responses, enhancing digestive ability, and demonstrating anti-aging effects. Evidence for immunomodulatory effects is predominantly in vitro and in animal models; robust human clinical trials evaluating immune endpoints have not been identified.

5.10 Anti-Radiation / Radioprotective Activity

Rosa roxburghii Tratt fruit has been reported to have antiatherogenic, antioxidant, antimutagenic, and radioprotective effects. These radioprotective claims are noted in preclinical literature but have not been substantiated by human clinical evidence identified in peer-reviewed sources.

6. Body Systems and Health Areas Associated with Rosa roxburghii

• Antioxidant / Oxidative Stress: Reduction of reactive oxygen species through both enzyme-based (SOD) and non-enzyme-based (vitamin C, polyphenols) mechanisms.
• Cardiovascular System: Preclinical and meta-analytic evidence for hypolipidemic effects (lowering total cholesterol, triglycerides, LDL; raising HDL), antiatherogenic activity.
• Metabolic Health / Diabetes: Inhibition of carbohydrate-digesting enzymes (α-amylase, α-glucosidase), reduction of fasting blood glucose and insulin resistance in animal models.
• Gastrointestinal System: Traditional use for digestive support, indigestion, stomach distension, diarrhea, and dysentery; preclinical evidence for gastric ulcer amelioration and gut microbiota modulation.
• Hepatic System: Preclinical evidence for protection against liver fibrosis, oxidative liver injury, and non-alcoholic fatty liver disease (NAFLD) via multiple signaling pathways.
• Oncology (preclinical only): In vitro evidence for antiproliferative and apoptosis-inducing effects in esophageal, gastric, and lung carcinoma cell lines.
• Skin Health: One human trial supporting improvements in skin hydration, elasticity, and melanin reduction from a multi-ingredient supplement containing R. roxburghii.
• Neurological System (preclinical only): Animal-model evidence for neuroprotection relevant to Parkinson's disease via PI3K/AKT signaling.
• Immune Function: Preclinical and traditional evidence for immunomodulatory activity; no confirmed human trial data.

7. Dosage Forms and Dosages Reported in Studies

Dosages vary substantially across studies depending on preparation form, plant part, and study objective. The following are dosages as reported in specific cited sources only:

• Oral supplement (juice, multi-ingredient with Punica granatum and rose): 20 mL of the RPR supplement daily on an empty stomach over 8 weeks was the dose used in the randomized clinical trial.
• Hydroalcoholic fruit extract (animal study, hyperlipidemia): Hydroalcoholic extract of Rosa roxburghii Tratt fruit (HRT) was evaluated in hyperlipidemic rats with significant reduction in body weight gain and serum and liver lipid levels observed. Precise mg/kg dosing levels were reported in the original study protocol.
• Ethyl acetate extract (historical toxicological study, animal): Intraperitoneal injection doses of ethyl acetate extract of Rosa roxburghii of 40 mg/kg and 20 mg/kg respectively were used for first and second groups; the third was a control group injected with physiological saline.
• Acute toxicity (animal, intraperitoneal, historical study): The LD50 of ethyl acetate extract injected intraperitoneally into mice was 273.0 ± 31.7 mg/kg (confidence limit: 95%).

No standardized oral dosage for human supplemental use has been established by a regulatory body or pharmacopeia. The clinical study used a multi-ingredient liquid formulation at 20 mL/day, and human dosage guidance remains absent from official monographs.

8. Safety Considerations

General Safety Profile

Previous research reports have examined the safety of R. roxburghii. As a fruit widely used for the dual purposes of medicine and food, no acute toxicity, long-term toxicity, mutagenicity, teratogenicity, or other adverse reactions have been found in toxicological studies.

In Vitro and Cell-Culture Safety

No cytotoxicity or genotoxicity was observed at levels of up to 5% (v/v) of the fruit extract. In addition, a significant protection against t-BHP-induced oxidative stress was observed in primary rat hepatocytes. The Ames test revealed no mutagenic activity using Salmonella typhimurium strains TA98, TA100, and TA102.

Clinical Safety Signal (Human)

In the single published randomized clinical trial using an oral multi-ingredient supplement containing Rosa roxburghii, no adverse effects were observed over the 8-week study period.

Astringency and Palatability

The fresh fruit of R. roxburghii has low acceptance for direct consumption due to its astringent taste. Processing into juices, fermented products, jams, or dried powders is standard practice and also reduces tannin-related astringency.

Knowledge Gaps and Limitations

The overall safety database for R. roxburghii as a concentrated dietary supplement in humans is extremely limited. Most toxicological data originate from animal studies. The hypolipidemic and other effects of R. roxburghii need to be confirmed by more research, especially in human clinical trials. No drug interaction data from human studies have been identified in the peer-reviewed literature. The extraordinarily high vitamin C content warrants awareness in the context of conditions where very high ascorbate intake may be relevant (e.g., renal oxalate stone risk at very high doses), though this has not been directly studied in R. roxburghii-specific trials.

9. Current Research Status and Summary of Evidence Quality

Bioactive compounds from Cili, comprising ascorbate derivatives, polyphenols, flavonoids, polysaccharides, triterpenoids, and sterols, act synergistically and exhibit antioxidant, anti-inflammatory, gastrointestinal, hepatoprotective, cardiovascular protective, anti-obesity, anti-diabetic, metabolic regulatory, anti-cancer, and neuroprotective effects. However, the overwhelming majority of this evidence derives from in vitro cell culture experiments, animal models, and network pharmacology / bioinformatics analyses.

While numerous extraction and purification techniques have successfully isolated and characterized bioactive components from R. roxburghii, comprehensive understanding of their chemical structure, mechanisms, structure-activity relationships, safety profiles, and practical applications remains limited. This knowledge gap hampers optimal utilization and development.

At the human clinical level, the evidence base consists of very few trials. The most notable published randomized trial evaluated a combined supplement (not R. roxburghii alone), was single-blinded with a small sample size, and was conducted over only 8 weeks. The lipid meta-analysis includes both human and animal studies and explicitly flags the need for additional human confirmation. No large-scale, double-blind, placebo-controlled trials with R. roxburghii as the sole intervention have been identified in any therapeutic area. In sum, R. roxburghii presents a compelling preclinical profile supported by a well-characterized phytochemistry, but human clinical evidence remains preliminary and insufficient to support definitive health claims for any specific indication.

References

• Jain A, et al. "Chemical diversity, traditional uses, and bioactivities of Rosa roxburghii Tratt: A comprehensive review." Pharmacology & Therapeutics, 2024. ScienceDirect.
• Xiang L-J, et al. "Biological Activities of Constituents from Rosa roxburghii and Their Mechanisms Based on Network Pharmacology and Biological Verification." International Journal of Molecular Sciences, 2025. PMC.
• Wang L, et al. "Recent Advances on Main Active Ingredients, Pharmacological Activities of Rosa roxburghii and Its Development and Utilization." Foods, 2023. PMC.
• "Free and Bound Phenolic Profiles of Rosa roxburghii Tratt Leaves and Their Antioxidant and Inhibitory Effects on α-Glucosidase." Frontiers in Nutrition, 2022.
• Hao Y, Wang Z, Qu L. "Investigating the Skin Health Benefits of Rosa roxburghii, Punica granatum and Rose: A Randomized Single-Blind Controlled Clinical Trial." Food Science & Nutrition, 2024. PMC.
• "Exploring the active components and potential mechanisms of Rosa roxburghii Tratt in treating type 2 diabetes mellitus based on UPLC-Q-exactive Orbitrap/MS and network pharmacology." PMC, 2023.
• "Effect of Rosa roxburghii fruit on blood lipid levels: a systematic review based on human and animal studies." International Journal of Food Properties, 2022. Taylor & Francis.
• van der Westhuizen FH, et al. "In vitro antioxidant, antimutagenic and genoprotective activity of Rosa roxburghii fruit extract." PubMed, 2008.
• "Inhibition of tumor growth in vitro by a combination of extracts from Rosa roxburghii Tratt and Fagopyrum cymosum." PubMed, 2012.
• "Rosa roxburghii fermented juice mitigates LPS-induced acute lung injury by modulation of intestinal flora and metabolites." PMC, 2024.
• "Cili (Rosa roxburghii Tratt.) as a Functional Food and Medicinal Resource: Current Advances and Future Directions." Current Issues in Molecular Biology, MDPI, 2026.
• "A review: Extraction of active ingredients, functional properties of Rosa roxburghii Tratt pomace and its application." ScienceDirect, 2025.
• "Antioxidant activity and whitening effect of vitamin C and superoxide dismutase from Rosa roxburghii Tratt." Food Quality and Safety, Oxford Academic, 2025.
• "Beneficial Effects of Hydroalcoholic Extract from Rosa Roxburghii Tratt Fruit on Hyperlipidemia in High-Fat-Fed Rats." PMC, 2020.
• "Polyphenol from Rosa roxburghii Tratt Fruit Ameliorates the Symptoms of Diabetes by Activating the P13K/AKT Insulin Pathway in db/db Mice." PMC, 2022.
• "Structure and antitumor activity of a polysaccharide from Rosa roxburghii." International Journal of Biological Macromolecules, ScienceDirect, 2024.
• "Exploring the Prevention of Lipid Deposition Caused by High-Fat Diet and Its Mechanism of Action of Rosa roxburghii Fermented Juice Based on Liver Metabolomics and Gut Microbiota." PMC, 2025.
• "Effect and Correlation of Rosa roxburghii Tratt Fruit Vinegar on Obesity, Dyslipidemia and Intestinal Microbiota Disorder in High-Fat Diet Mice." PMC, 2022.
• "A Proanthocyanidins-Rich Cili (Rosa roxburghii) Fruit Extract Protects CCl4-Induced Mouse Hepatic Fibrosis via Modulation of Ferroptosis and Gut Microbiota." PMC, 2025.
• "Research on the effect of Rosa roxburghii root in alleviating spleen and stomach damp-heat gastric ulcer by regulating the imbalance of oral-gut axis microbiota." PMC, 2025.
• "Identifying the Mechanisms of Rosa Roxburghii Tratt on Treating Gastric Cancer: Combining the Targetable Screening From the Cancer Genome Atlas With Network Pharmacology." Natural Product Communications, SAGE, 2021.
• "Two New Alkaloids and a Triterpenoid Glycoside from Rosa roxburghii with Antioxidant and Enzyme Inhibitory Activities." Antioxidants, MDPI, 2026.
• "Neuroprotective Effects of Rosa roxburghii Tratt Juice Concentrate Powder in Parkinson's Disease Mice via the PI3K/AKT Signaling Pathway." Pharmaceuticals, MDPI, 2026.
• "Protective Mechanism of Rosa roxburghii Tratt Fermentation Broth against Ultraviolet-A-Induced Photoaging of Human Embryonic Skin Fibroblasts." Antioxidants, PMC, 2024.
• "Dynamic Changes of Active Components and Volatile Organic Compounds in Rosa roxburghii Fruit during the Process of Maturity." PMC, 2024.
• "Purification, Characterization, and Anti-Inflammatory Potential of Free and Bound Polyphenols Extracted from Rosa roxburghii Tratt Pomace." Foods, PMC, 2024.
• "Regulation mechanism of Rosa roxburghii Tratt. (Cili) fruit vinegar on non-alcoholic fatty liver disease." PMC, 2025.
• "Nutritional constituents, health benefits and processing of Rosa Roxburghii: A review." Journal of Functional Foods, ScienceDirect, 2019.
• "Comparative analysis of multiple ingredients in Rosa roxburghii and R. sterilis fruits and their antioxidant activities." Journal of Functional Foods, ScienceDirect, 2016.
• ClinicalTrials.gov NCT06274450. "A Clinical Study on the Improvement of Skin and Living Conditions After Drinking Rosa Roxburghii and Pomegranate Drinks."